HUP9701598A2 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
HUP9701598A2
HUP9701598A2 HU9701598A HUP9701598A HUP9701598A2 HU P9701598 A2 HUP9701598 A2 HU P9701598A2 HU 9701598 A HU9701598 A HU 9701598A HU P9701598 A HUP9701598 A HU P9701598A HU P9701598 A2 HUP9701598 A2 HU P9701598A2
Authority
HU
Hungary
Prior art keywords
acetate
days
noretisteron
active agents
pharmaceutical composition
Prior art date
Application number
HU9701598A
Other languages
Hungarian (hu)
Inventor
György Siklósi
Csaba Elek
Gyuláné Németh Zsuzsanna Tímár
Original Assignee
György Siklósi
Csaba Elek
Gyuláné Németh Zsuzsanna Tímár
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by György Siklósi, Csaba Elek, Gyuláné Németh Zsuzsanna Tímár filed Critical György Siklósi
Priority to HU9701598A priority Critical patent/HUP9701598A2/en
Publication of HU9701598D0 publication Critical patent/HU9701598D0/en
Publication of HUP9701598A2 publication Critical patent/HUP9701598A2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The contraceptive product comprises 3 types of tablets: one for days 1-14; one for days 15-29; and one for days 27-28. 12 alternative active agents and their quantities per tablet are given for each type. The active agents comprises levenorgestel, medroxi-progesterone acetate, ciproteron acetate, chloromadinon-acetate, noretisteron, noretisteron acetate, linestrenol. etidiom diacetate, noretinodrel, dezogestrel, norgestimate or gestoden.
HU9701598A 1997-10-01 1997-10-01 Pharmaceutical composition HUP9701598A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HU9701598A HUP9701598A2 (en) 1997-10-01 1997-10-01 Pharmaceutical composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9701598A HUP9701598A2 (en) 1997-10-01 1997-10-01 Pharmaceutical composition

Publications (2)

Publication Number Publication Date
HU9701598D0 HU9701598D0 (en) 1997-11-28
HUP9701598A2 true HUP9701598A2 (en) 1999-07-28

Family

ID=89995630

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9701598A HUP9701598A2 (en) 1997-10-01 1997-10-01 Pharmaceutical composition

Country Status (1)

Country Link
HU (1) HUP9701598A2 (en)

Also Published As

Publication number Publication date
HU9701598D0 (en) 1997-11-28

Similar Documents

Publication Publication Date Title
HUP9601566A2 (en) Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component
CA2180816A1 (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
CA2193337A1 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
ZA962536B (en) Pharmaceutical composition for transdermal administration.
FI960032L (en) Pharmaceutical compositions for poorly soluble active ingredients
IL138028A0 (en) Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical use
HUP9800792A3 (en) Benzylpiperidines and piperazines, their use and pharmaceutical compositions containing the same
EP0645136A3 (en) Physiologically active substance-prolonged releasing-type pharmaceutical preparation.
IL106141A0 (en) Thiazolylvinylphenyl derivatives,their manufacture and pharmaceutical compositions containing them
ZA965294B (en) Substituted 4-phenylaminothiazoles, their process of preparation and the pharmaceutical compositions containing them.
PL331709A1 (en) Cytotoxic aminosaccharic and affinite saccharic derivatives of indolopyrrole carbazoles
GB9520584D0 (en) Pyrazole derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
ZA967546B (en) Pharmaceutical formulation.
GB2271059B (en) Pharmaceutical compositions comprising aconitane derivatives and tetrahydroprotoberberine derivatives.
HUP9700005A3 (en) 2-ureido-benzamide derivatives and pharmaceutical compositions containing them as active agent
NO950537D0 (en) Polysubstituted 3-acylamino-5-phenyl-1,4-benzodiazepin-2-one derivatives, processes for their preparation, and pharmaceutical compositions containing them
HUP9801880A3 (en) Novel cryptophycins, their use and pharmaceutical compositions containing them
HUP9802408A3 (en) Naphthyl and dihydronaphthyl-derivatives, and pharmaceutical compositions, containing them
HUP9801386A3 (en) Indazolecarboxamide derivatives, preparation thereof and pharmaceutical compositions containing them
IL105942A0 (en) Biologically active eburnamenine derivatives,their preparation and pharmaceutical compositions containing them
IL139318A0 (en) Sugar alcohol mixtures as therapeutic agents and pharmaceutical compositions containing the same
HUP9901485A3 (en) Heterocyclylcarboxamide derivatives, pharmaceutical compositions containing the same, process for their preparation and their use
NO305286B1 (en) Quinoxaline compounds, pharmaceutical preparations comprising them, and their use in the manufacture of medicaments
IL117067A (en) Anti-neurodegeneratively active 10-aminoaliphatyl-dibenz¬b,f¾oxepines their preparation and pharmaceutical compositions containing them
ZA967288B (en) Products and processes for the sustained release of agricultural active ingredients.